Contract award · 21 Oct 2025

NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 1 – NHS North-West GMS

NHS England awarded a contract to Manchester University NHS Foundation Trust, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Birmingham Women's…

No competitionHealth & social careNorth West

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Buyer
NHS England · Body governed by public law
Value
£36,225,000,000 across 7 lots
Procedure
Award procedure without prior publication of a call for competition
Sector
Health & social care · Health services (CPV 85100000)
Timeline
  1. Contract date21 Oct 2025
  2. Published23 Oct 2025Published 2 days after the contract date

Description

Pursuant to the NHS GMS contracts, providers are to provide the following functions:<br/>* Organisational leadership, governance and partnership arrangements;<br/>* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);<br/>* Laboratory operating model;<br/>* Clinical function: cancer genomics;<br/>* Clinical function: rare disease;<br/>* Clinical function: population health;<br/>* Promotion of and supporting and leading where relevant science, research and / or innovation;<br/>* Transformation and Service Improvement;<br/>* People – workforce, education and training; and<br/>* Data and digital<br/>The Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.<br/>The approximate lifetime value of the contract for all Lots is £5,175,000,000.<br/>The services will start on 1st April 2026 and the initial period …

Lots in this award

LotSupplierValue
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 1 – NHS North-West GMSManchester University NHS Foundation Trust£5.17bn
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 2 – NHS North-East and Yorkshire GMSThe Newcastle upon Tyne Hospitals NHS Foundation Trust£5.17bn
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 3 – NHS Central and South GMSBirmingham Women's and Children's NHS Foundation Trust£5.17bn
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 4 – NHS East GMSCambridge University Hospitals NHS Foundation Trust£5.17bn
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 5 – NHS South-West GMSNorth Bristol NHS Trust£5.17bn
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 6 – NHS North Thames GMSGreat Ormond Street Hospital for Children NHS Foundation Trust£5.17bn
NHS Genomic Medicine Service - Most Suitable Provider Process: Lot 7 – NHS South-East GMSGuy's and St Thomas' NHS Foundation Trust£5.17bn

About the suppliers

More from NHS England

All contracts

More won by Manchester University NHS Foundation Trust

All contracts

Recent health & social care contracts

Sector overview